An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy

Abstract

HR-MAS MR metabolomics on intact breast tissues obtained by core needle biopsy may have a potential to be used as a complement to the current diagnostic and prognostic measures for breast cancers.